AIxCrypto Establishes Web3 Subsidiary in UAE and Obtains License Approval
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 23 2025
0mins
AIxCrypto announced the establishment of a regulated Web3-focused subsidiary in the United Arab Emirates and obtained Web3 license approval from local government, subject to final administrative processing. Established in Ras Al Khaimah Innovation City, AIxC's RAK Web3 operations license represents a foundational infrastructure decision-enhancing regulatory certainty, capital access, operational flexibility, and long-term scalability while positioning AIxC at the center of one of the world's most strategically important crypto hubs.
Analyst Views on AIXC
About AIXC
AIxCrypto Holdings, Inc., formerly Qualigen Therapeutics, Inc., is focused on building an ecosystem that integrates Artificial Intelligence (AI) and blockchain, bridging Web2 and Web3. This ecosystem unites a decentralized protocol, distributed network, AI DePIN and EAI RWA value regeneration, and a DeAI Agent product and technology platform designed to achieve optimal trading performance. Its core products include the BesTrade DeAI Agent and the AIxC ecosystem products. Its crypto business, CXC10, is centered on three growth engines which include six key products: C - Crypto 10 (C10) as Value Anchor, X - DeAI Agent, and C - RWA & Ecosystem Tokens. C - Crypto 10 (C10) as Value Anchor - through the C10 Digital Asset Treasury, C10 Index, and a potential C10 ETF. C - RWA & Ecosystem Tokens - including the C10 Stablecoin and the EAI + Crypto Dual-Bridge Real World Asset product, bridging traditional assets with Web3. It also develops and commercializes oncology and immunology therapies.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
